UBS Group’s Gentex GNTX Stock Holding History

UBS Group’s Portfolio GNTX Stock Details GNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-520,300	Closed	-$8.33M	–	7837
2015 Q4	$8.33M	Buy	+520,300	New	+$8.41M	0.01%	1536

Other funds holding GNTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group's GNTX Position: Q1 2026 in Review

UBS Group reduced its Gentex (GNTX) stake by 7% in Q1 2026, selling an estimated $2.63M and leaving 1,509,382 shares worth $33M. The position accounts for ﹤0.01% of the portfolio, ranked #2073.

UBS Group first reported a position in GNTX in Q4 2014 and has held it in 46 quarters since. The position peaked at $98M in Q2 2025. 501 funds tracked by Wall St. Rank hold GNTX as of Q1 2026.

UBS Group held 1,509,382 shares of Gentex worth $33M as of Q1 2026.
UBS Group sold 113,661 Gentex shares in Q1 2026, an estimated $2.63M.
Gentex made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2073 holding.
UBS Group first reported a position in Gentex in Q4 2014 and has held it in 46 quarters since.
UBS Group's Gentex position peaked at $98M in Q2 2025.
501 funds tracked by Wall St. Rank held Gentex as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.